news aktuell GmbH

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Share

Darmstadt, 7 December 2021 – R-Biopharm, an international specialist in clinical diagnostics, announces that the company’s RIDA®GENE Flu & SARS-CoV-2 multiplex test (PG6825) has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) Regulations 2021 (“CTDA”). R-Biopharm will now work to resume the sale of the product in the UK.

RIDA®GENE Flu & SARS-CoV-2 test is a multiplex real-time RT-PCR for the direct qualitative detection and differentiation of Flu A/Flu B and coronavirus (SARS-CoV-2) RNA in human nasal/throat swabs from persons with signs and symptoms of respiratory infection. It is intended for professional use for example in hospital laboratories, reference laboratories, private laboratories, or public laboratories. The RIDA®GENE Flu & SARS-CoV-2 multiplex test targets the M gene/NP1 gene of the virus for Influenza A/B and the E gene and RdRpgene in all currently known variants and mutations of the COVID 19 virus.

Only validated products, or products on the temporary protocol, can be sold in the UK after 31 October 2021. Jason Baggaley, Sales Manager of R-Biopharm for Great Britain, commented: “We are proud that our RIDA®GENE Flu & SARS-CoV-2 test was approved and added to the CTDA register and our customers will continue to be able to distinguish between the flu and an infection with the Corona virus.“

 Press contact:

Simone Feiler
Head of Corporate Brand Communication
https://r-biopharm.com 
https://r-biopharm.com/news-press

R-Biopharm AG
An der neuen Bergstraße 17
64297 Darmstadt, Germany

Tel.: 0 61 51 - 81 02-538
Mobile: 0 160 - 55 273 60
Fax: 0 61 51 - 81 02-40

Email: s.feiler@r-biopharm.de 

Images

About news aktuell GmbH

news aktuell GmbH
news aktuell GmbH
Mittelweg 144
20148 Hamburg

+49 (0)40 4113-32589http://www.newsaktuell.de

As wholly owned subsidiary of dpa, news aktuell provides business and organizations with effective access to media and consumers. Via the smart tools ots and zimpel, PR content accesses all media formats, including classical print, high click-rate online portals and social networks. In addition, news aktuell publishes all its customers’ PR content on www.presseportal.de, one of the PR portals with the greatest reach in Germany. By this means, all the relevant multipliers are reached globally, from editors, via digital influencers right up to specialist bloggers and interested consumers. news aktuell has been on the market since 1989. The company, with a staff complement of more than 135, has its headquarters in Hamburg. Other offices are in Berlin, Dusseldorf, Frankfurt und Munich.

Subscribe to releases from news aktuell GmbH

Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from news aktuell GmbH

Hope Spot Ocean? – combining conservation and sustainable use19.1.2022 13:29:16 CET | Pressemelding

The new World Ocean Review: Communicating the latest marine knowledge understandably. More than ten years after the first edition of the World Ocean Review (WOR), maribus gGmbH and their scientific partners, the German Marine Research Consortium (KDM) and the Kiel Future Ocean Network, are publishing the next WOR that reviews the overall situation of the oceans. Its conclusion: only together can we achieve solutions for a sustainable future of the ocean by balancing protection and sustainable use. In order to achieve those sustainable solutions, important transformations in the way humans interact with the ocean must be initiated quickly. The new WOR is freely available to download and printed copies can be ordered.

Visable GmbH: Record year 2021: Platform provider Visable reports 66 million euro turnover12.1.2022 15:49:54 CET | Press release

(Hamburg, Germany): – Visable, the provider of Europe’s leading B2B platforms EUROPAGES and wlw (formerly “Wer liefert was”), reports its most successful year yet: Overall, the company was able to achieve a profitable record turnover of 66 million euros. This constitutes a growth of 14 per cent compared to the previous year. "We are very satisfied and pleased with our performance in 2021, despite the ongoing COVID crisis. In particular, we were once again able to significantly increase our new customer business with a plus of 15 per cent compared to 2020 thanks to the continuous improvement of our platforms," says Visable CEO Peter F. Schmid.

Aras Announces Minerva Merger for Best-in-Class PLM Functionality in Medical Devices and High-Tech Electronics11.1.2022 16:15:39 CET | Pressemelding

– Aras, which provides the most powerful low-code platform with applications to design, build, and operate complex products, today announced the merger of Minerva Group, the leading Aras Innovator PLM implementation partner. Minerva brings best-in-class PLM functionality—built on the Aras platform—for medical devices and high-tech electronics companies. The company also brings extensive vertical industry expertise in automotive, aerospace, defense, and industrial equipment manufacturing, and will provide Aras with direct, local representation in the Nordic region and the Netherlands. The merger is effective immediately.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom